NEW DELHI: Sun Pharmaceutical Industries Ltd on Friday said it has commenced phase-II clinical trial of AQCH, a phytopharmaceutical or a plant derived drug, for the treatment of covid-19.

The CSIR is exploring a native herb as a biological medicine or phytopharmaceutical, which is already being tested as medicine for dengue for its efficacy to combat COVID-19.

New Delhi: The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - 'favipiravir' and ...

Frutarom Health BU, Switzerland, announces the launch of EFLA®pharm, a flagship proprietary product line comprised of both phytopharmaceutical ingredients and pharma flavors. The new product line ...

The EFLApharm family of products are scientifically supported, natural, pharmaceutical-grade herbal extracts. All are produced according to strict GMP guidelines ...

Phytopharmaceutical drugs are a fraction of crude extract and are distinctly differentiated by being purified and standardized. There is a separate category of PPI monograph in IP where an herbal drug ...

The two phytopharmaceutical leads - Cannabis Sativa for pain management and Boswellia Serrata for rheumatoid arthritis treatment - are being developed under the tripartite agreement between the ...

The Drug Controller General of India (DGCI) has given green signal to the Council for Scientific and Industrial Research (CSIR) to conduct clinical trial on drugs - 'favipiravir' and ...

Frutarom Health BU reports it will strengthen focus on its phytopharmaceutical business in 2017. This follows the 2016 acquisition of Extrakt Chemie GmbH & Co.KG, in Stadhagen, near Hannover ...

WAEDENSWIL, Switzerland, February 6, 2017 /PRNewswire/ -- FrutaromStrengthenitsPositionin Germany Frutarom Health BU reports it will strengthen focus on ...